Scientific Advisory Board
The Scientific Advisory Board is made up of individuals holding a D.V.M, M.D., or Ph.D. They are all successful and highly regarded researchers in a variety of disciplines including, but not limite,d to veterinary researchers, geneticists, and molecular and other biological scientists.
Jaime F. Modiano, V.M.D., Ph.D.
Perlman Professor of Oncology/Comparative Medicine
University of Minnesota
College of Veterinary Medicine and Masonic Cancer Center
Dr. Jaime F. Modiano is from from Mexico City, where he graduated from the baccalaureate program at Colegio Columbia. He did undergraduate work in Biomedical Sciences at Texas A&M University in College Station, TX for three years before moving on to veterinary school at the University of Pennsylvania. He completed his veterinary training and PhD in Immunology at Penn, followed by a residency in Veterinary Clinical Pathology at Colorado State University, and a post-doctoral fellowship at the National Jewish Center for Immunology and Respiratory Medicine. He was appointed to the faculty in the Department of Veterinary Pathobiology at Texas A&M University as Assistant Professor between 1995 and 1999. Dr. Modiano returned to Denver, CO in 1999 where he remains as a Senior Scientist at the AMC Cancer Center, Associate Professor of Immunology, and Full Member of the Cancer Center at the University of Colorado Health Sciences Center. His research program is supported through federal and private sources. Dr. Modiano has co-authored more than 40 peer-reviewed scientific manuscripts, and over 80 abstracts, presentations, and book chapters focused on various aspects of immunology, cancer cell biology, the genetic basis of cancer and applications of gene therapy
Dr Michael S. Kent
Center for Companion Animal Health (CCAH)
Department of Surgical and Radiological Sciences
School of Veterinary Medicine
University of California, Davis
Dr. Michael S. Kent graduated from the UC Davis School of Veterinary Medicine in 1997. He then went on to do a small animal internship at the University of Pennsylvania, where his interest in oncology developed. After working for a year in private practice in Pennsylvania he went on to do residencies in both Medical and Radiation Oncology at the University of California at Davis. Dr. Kent was then hired as an Assistant Professor at the same university. Dr. Kent is board certified diplomate in Medical and Radiation Oncology. To receive further training he enrolled in an NIH sponsored two year Mentored Clinical Research Training Program. He is currently director of the Medical Oncology Residency program at the school. His current research interests include the modulation of the radiosensitivity of melanoma, and innovative therapeutics for lymphoma and Osteaosarcoma.
Dr. Kim Selting
Assistant Teaching Professor
University of Missouri
A native of Colorado, Dr. Kim Selting completed her undergraduate and veterinary studies at Colorado State University. Following a one year rotating small animal internship in medicine and surgery at the Animal Medical Center, she then moved to St. Louis. There Dr. Selting spent one year in emergency work and 3 years in small animal private practice. She then returned to the Colorado State University Animal Cancer Center to pursue a residency in medical oncology. At the completion of this training, Dr. Selting had earned a Master’s degree and was board-certified by the American College of Veterinary Internal Medicine in the specialty of Oncology. Dr. Selting then joined the faculty at the University of Missouri and has remained there since 2002. Professional clinical and research interests include biomarkers of cancer and chemotherapy toxicity, novel chemotherapy drugs and treatments, and more recently inhalant chemotherapy and exhaled breath condensate evaluate in the monitoring and treatment of primary and metastatic lung cancer. Past professional roles include President of the Veterinary Cooperative Oncology Group, member-at-large for the Veterinary Cancer Society, and Chair of the Oncology Certifying Examination Committee. She is currently pursuing specialty certification in Radiation Oncology.
Dr. Nicola Mason
Assistant Professor of Medicine & Pathobiology
University of Pennsylvania
Nicola Mason graduated from the Royal Veterinary College, London in 1992 and spent a year in private small animal practice. She performed a small animal internship at the University of Bristol and then an internal medicine residency at the University of Pennsylvania’s School of Veterinary Medicine. She became a member of the American College of Veterinary Internal Medicine in 1998. She earned her PhD in Immunology from the University of Pennsylvania and spent several years as a post doctoral research fellow in the laboratory of Dr. Carl June at the University of Pennsylvania’s School of Medicine. She joined the faculty of the Veterinary School at the University of Pennsylvania in 2006. Her research focuses on understanding the pathophysiological mechanisms involved in canine lymphoma and identification of tumor associated antigens that may be targeted by the immune system. She holds the Pamela Cole Chair in Companion Animal Medicine, is an Associate Director of the Mari Lowe Center for Comparative Oncology and is the Director of the PennVet Tumor Tissue Bank.